Aeglea BioTherapeutics, Inc. reports $18.4 million Q1 loss
The company generated $0.20 million in quarterly revenue
By USInMinutes
Published - May 11, 2023, 10:11 AM ET
Last Updated - Aug 28, 2024, 02:20 AM EDT
Aeglea BioTherapeutics, Inc. [AGLE] has reported fiscal Q1 loss of $18.40 million.
On a per-share basis, the DE based company said its diluted earnings are $0.20 .
The Pharmaceutical Preparations firm posted revenue of $0.20 million in this period.
